Tag: Biotech and Pharma

Novo Nordisk shares fall after media report about quality lapses at U.S. plant

Novo Nordisk’s shares fell on Monday after financial news agency MarketWire reported that U.S. drug regulators had recently issued a report detailing quality control lapses at the group’s Clayton, North Carolina plant, citing sources.

Novartis shareholders vote in favour of Sandoz spin-off

 Novartis shareholders on Friday voted in favour of spinning off the Swiss company’s generic-drugs business Sandoz, with investors holding 99.7% of the represented capital supporting the complete separation.

Moderna Rises on Positive Results From Flu Vaccine, and Other Plans to Move Beyond Covid

Moderna stock was rising Wednesday after the vaccine maker released positive results from a Phase 3 trial of its mRNA flu vaccine and provided insight on its plans for other vaccines targeting cancer and other diseases

Lilly’s diabetes drug Mounjaro approved by UK watchdog

 Eli Lilly’s diabetes drug Mounjaro has gained the backing of Britain’s healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly controlled type 2 diabetes.

Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia

Scientists have begun investigating whether so-called miracle obesity drugs could be used to treat conditions such as dementia and alcohol addiction after recent trials pointed to the drugs’ efficacy in treating serious health issues.

Moderna says updated Covid vaccine was effective against highly mutated BA.2.86 variant in trial

Moderna’s new Covid vaccine generated a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, according to clinical trial data the biotech company released Wednesday.

J&J forecasts 12.5% growth in 2023 profit after Kenvue spinoff

Johnson & Johnson on Wednesday forecast 12.5% growth in its annual adjusted profit after completing the separation of consumer health company Kenvue .

Dechra, Hikma, M&S and Diploma set to join FTSE 100

 Drugmakers Dechra and Hikma along with retailer Marks & Spencer  and technical products provider Diploma are set to join the UK’s blue-chip FTSE 100 index in September, indicative changes announced by FTSE Russell show.

Novavax’s updated COVID vaccine shows response against ‘Eris’ variant

Novavax Inc said on Tuesday its updated protein-based COVID-19 vaccine generated an immune response against the “Eris” subvariant in preclinical studies.

Moderna says new Covid vaccine was effective against Eris variant in early trial

Moderna’s new Covid vaccine generated a robust immune response against the now-dominant Eris variant and another rapidly spreading strain of the virus in an early clinical trial, the biotech company said Thursday. 

New Covid Strain Arrives as Vaccine Makers Gear Up

The latest version, which some are calling Eris, is now a “variant of interest” at the World Health Organization, having been reported in at least 51 countries since early August, including China, the U.S., Korea, Japan, and Canada.

Wegovy-maker Novo Nordisk extends curb on supply of weight-loss drug, raises outlook

Novo Nordisk, which makes blockbuster drug Wegovy, raised its outlook for 2023 Thursday but said it is extending supply restrictions for some doses of the weight-loss drug.

Kenvue Will be Added to S&P 500 After J&J Exchange Offer

Kenvue–0.13% will join the S&P 500SPX –0.70% following the completion of Johnson and Johnson JNJ –0.06% ’s exchange offer for Kenvue stock, according to S&P Dow Jones Indices.

Novo Nordisk shares pop after key trial data shows Wegovy cuts risk of heart attack or stroke by 20%

Shares of Danish drugmaker Novo Nordisk soared on Tuesday, after late-stage trial data showed that its obesity drug Wegovy reduced the risk of major cardiovascular events such as heart attacks or strokes by 20%, compared with a placebo.

Eli Lilly Stock Is Flying After Strong Results. Obesity Drugs Delivered the Goods.

Eli Lilly stock was flying on Tuesday after the drugmaker recorded quarterly profit and revenue well ahead of Wall Street’s expectations. Sales of obesity drugs are delivering the goods.

BioNTech Stock Drops. What’s Behind Today’s Fall.

Shares of BioNTech, the German company that developed a Covid-19 vaccine with Pfizer , were falling in early trading Monday after second-quarter revenue missed expectations.the U.S. dollar strengthened versus major rivals.

Moderna Raises Guidance for Covid-19 Vaccine Sales. The Stock Is Rising.

Moderna shares were rising early Thursday after the company reported lighter losses and better revenue than expected for the June quarter and raised guidance for sales of its Covid-19 vaccine.

Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal

Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil.

Reata Stock Surges. Biogen Is Buying It for $7.3 Billion in Cash.

Biogen  said Friday it will acquire Reata Pharmaceuticals   in a deal valued at $7.3 billion.

Eli Lilly’s obesity drug succeeds in two late-stage studies

July 27 (Reuters) – Eli Lilly (LLY.N) said on Thursday its experimental obesity drug met the main goals in two late-stage studies, with the drug helping patients reduce 26.6% weight on average in one of the studies following intensive lifestyle changes.